Skip to content

Variant type and patient sex affect molnupiravir efficacy, study finds

  • by
  • blog
  • 1 min read

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study.


Join the conversation

Your email address will not be published. Required fields are marked *